Dr Tina Noutsos

Outstanding Future Researcher/Senior Research Fellow


Doctor of Philosophy, Charles Darwin University, 2021; Graduate Australian Institute Company Directors, 2021; Fellow Royal Australasian College of Physicians, 2010; Fellow Royal College Pathologists of Australasia, 2010; Bachelor of Medicine Bachelor of Surgery, Flinders University, 1999; Bachelor of Science, University of Melbourne, 1996

Approved level of HDR supervision at Charles Darwin University:



Darwin – Royal Darwin Hospital campus


Dr Tina Noutsos is a Senior Research Fellow at Menzies, Senior Specialist Clinical and Laboratory Haematologist at Royal Darwin Hospital, and Associate Professor at Flinders University.

Tina has clinical research interests in critical bleeding, blood transfusion, thrombotic microangiopathies, global and Indigenous health. Her research with the Australian Snakebite Project on snakebite-associated thrombotic microangiopathy has established the global epidemiology, diagnostic criteria, effectiveness of treatments, and long-term outcomes of this important complication of snakebite.

Tina is a chief investigator on a National Blood Authority research grant investigating blood transfusion outcomes in First Nations people admitted to intensive care, and women and babies during childbirth across the NT, together with NT patients referred to South Australia for heart surgery. She has recently joined the Blood Synergy Group, an NHMRC-funded program of research focused on addressing Australia’s national transfusion priorities. Tina also supervises research projects on immune related blood conditions which disproportionately affect First Nations Territorians: Antiphospholipid Antibody Syndrome and Immune Thrombocytopenic Purpura.

Tina has a solid foundation in medical education and leadership and was previously Director of the Flinders University Doctor of Medicine (2017-2020), the NT Medical Program Course Director (2015-2020), and acting Associate Dean for Flinders NT (2016).

Research Themes
  • Are red cell transfusion requirements and patient outcomes in Aboriginal and Torres Strait Island (First Nations) versus non-Aboriginal Torres Strait Island people different? A Northern Territory and South Australian multicentre five year retrospective cohort study
  • Clinical outcomes of Antiphospholipid Antibody Syndrome in the Northern Territory
  • Clinical outcomes of Immune Thrombocytopenic Purpura in the Northern Territory
  • The Australian Snakebite Project
  • Blood Synergy - addressing Australia’s national transfusion priorities
  • Thrombotic Microangiopathies national registry
  1. Noutsos, T., Currie, B.J., Wijewickrama, E.S., & Isbister, G.K. (2022). Snakebite Associated Thrombotic Microangiopathy and Recommendations for Clinical Practice. Toxins, 14(1), 57. https://doi.org/10.3390/toxins14010057
  2. Noutsos, T., Currie, B.J., Isoardi, K.Z., Brown, S.G., & Isbister, G.K. (2021). Snakebite associated thrombotic microangiopathy: an Australian prospective cohort study [ASP30]. Clinical Toxicology. https://doi.org/10.1080/15563650.2021.1948559
  3. Noutsos, T., Laidman, A.Y., Survela, L., Arvanitis, D., Segalla, R., Brown, S.G., & Isbister G.K. (2021). An evaluation of existing manual blood film schistocyte quantitation guidelines and a new proposed method. Pathology, 53(6), 746-752. https://doi.org/10.1016/j.pathol.2021.01.008
  4. Noutsos, T., Currie, B.J., Brown, S.G., & Isbister, G.K. (2021). Schistocyte quantitation, thrombotic microangiopathy and acute kidney injury in Australian snakebite coagulopathy [ASP28]. International Journal of Laboratory Hematology, 43, 959-965. https://doi.org/10.1111/ijlh.13497
  5. Ramamoorthy, S.K., Noutsos, T., Wei, D., Laidman, A.Y. & Szabo,F. (2020). Recurrent and refractory hemophagocytic lymphohistiocytosis in an elderly. Role of immune aberration due to myeloid gene mutation. Blood, 136, Supplement 1, 24-26. https://doi.org/10.1182/blood-2020-133776
  6. Noutsos, T., Currie, B.J., Lek R.A. & Isbister, G.K. (2020). Snakebite associated thrombotic microangiopathy: a systematic review of clinical features, outcomes, and evidence for interventions including plasmapheresis. PLOS Neglected Tropical Diseases, 14(12), e0008936. https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008936
  7. Noutsos, T., Currie, B.J. & Isbister, G.K. (2019). Snakebite associated thrombotic microangiopathy: a protocol for the systematic review of clinical features, outcomes, and role of interventions. Systematic Reviews, 8(212). https://doi.org/10.1186/s13643-019-1133-2
  8. Patil, S., Spencer, A., Schwarer, A., Lewis, I., Hertzberg, M., Avery, S., Wei, A., Noutsos, T., Paul, E., Taouk, Y., & Muirhead, J. (2010). Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-up. Bone Marrow Transplant, 45, 1154–1160. https://doi.org/10.1038/bmt.2009.322
  9. Worley, P., Lowe, M., Notaras, L., Strasser, S., Kidd, M., Slee, M., Williams, R., Noutsos, T., & Wakerman, J. (2019). The Northern Territory Medical Program – growing our own in the NT. Rural and Remote Health, 19, 4671. https://doi.org/10.22605/RRH4671
  10. Campbell, N., Kennedy, E., Rissel, C., Gill, E., Bergin, S., Noutsos, T., & O'Donoghue, O. (2021). Workplace locations of 2011–2017 Northern Territory Medical Program graduates. Rural and Remote Health, 21, 6662. https://doi.org/10.22605/RRH6662